GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nuwellis Inc (FRA:22SA) » Definitions » Cyclically Adjusted PS Ratio

Nuwellis (FRA:22SA) Cyclically Adjusted PS Ratio : 0.00 (As of Jun. 08, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Nuwellis Cyclically Adjusted PS Ratio?

As of today (2024-06-08), Nuwellis's current share price is €0.1928. Nuwellis's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €7,711.31. Nuwellis's Cyclically Adjusted PS Ratio for today is 0.00.

The historical rank and industry rank for Nuwellis's Cyclically Adjusted PS Ratio or its related term are showing as below:

During the past years, Nuwellis's highest Cyclically Adjusted PS Ratio was 365.53. The lowest was 0.01. And the median was 0.07.

FRA:22SA's Cyclically Adjusted PS Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.17
* Ranked among companies with meaningful Cyclically Adjusted PS Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Nuwellis's adjusted revenue per share data for the three months ended in Mar. 2024 was €0.272. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €7,711.31 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Nuwellis Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Nuwellis's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuwellis Cyclically Adjusted PS Ratio Chart

Nuwellis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.05 0.01 - -

Nuwellis Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Nuwellis's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Nuwellis's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nuwellis's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nuwellis's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Nuwellis's Cyclically Adjusted PS Ratio falls into.



Nuwellis Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Nuwellis's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.1928/7711.31
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuwellis's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Nuwellis's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.272/131.7762*131.7762
=0.272

Current CPI (Mar. 2024) = 131.7762.

Nuwellis Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.000 100.560 0.000
201409 0.000 100.428 0.000
201412 0.000 99.070 0.000
201503 0.000 99.621 0.000
201506 0.000 100.684 0.000
201509 0.000 100.392 0.000
201512 0.000 99.792 0.000
201603 0.000 100.470 0.000
201606 0.000 101.688 0.000
201609 0.000 101.861 0.000
201612 0.000 101.863 0.000
201703 0.000 102.862 0.000
201706 0.000 103.349 0.000
201709 0.000 104.136 0.000
201712 0.000 104.011 0.000
201803 0.000 105.290 0.000
201806 9,410.000 106.317 11,663.388
201809 10,618.182 106.507 13,137.424
201812 7,752.941 105.998 9,638.428
201903 1,075.000 107.251 1,320.828
201906 1,484.000 108.070 1,809.538
201909 1,137.000 108.329 1,383.092
201912 615.000 108.420 747.485
202003 295.000 108.902 356.965
202006 127.231 108.767 154.146
202009 80.800 109.815 96.959
202012 62.222 109.897 74.610
202103 50.344 111.754 59.364
202106 32.031 114.631 36.822
202109 22.183 115.734 25.258
202112 13.838 117.630 15.502
202203 16.657 121.301 18.095
202206 19.933 125.017 21.011
202209 19.867 125.227 20.906
202212 4.119 125.222 4.335
202303 1.514 127.348 1.567
202306 1.442 128.729 1.476
202309 1.212 129.860 1.230
202312 0.412 129.419 0.420
202403 0.272 131.776 0.272

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Nuwellis  (FRA:22SA) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Nuwellis Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Nuwellis's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuwellis (FRA:22SA) Business Description

Traded in Other Exchanges
Address
12988 Valley View Road, Eden Prairie, MN, USA, 55344
Nuwellis Inc is a medical device company. Its solutions include Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.

Nuwellis (FRA:22SA) Headlines

No Headlines